Generate a tailored SOP for Dr. Laurence Wakelin. Improve your application with a focused, well-structured draft.
Associate Professor Laurence Wakelin specializes in the fields of pharmacology and cancer research. He received his Bachelor's degree with first-class honors in Chemistry from the University of Kent in the United Kingdom in 1971, and his PhD in Pharmacology from Clare College, University of Cambridge in 1975. His early career included fellowships at the Department of Pharmacology at the University of Cambridge and senior scientist roles at the Peter MacCallum Cancer Institute in Melbourne. Subsequently, he joined University College Dublin as a Professor of Cancer Research. Since 1999, he has been associated with the School of Medical Sciences at UNSW, where he became an Honorary Associate Professor in 2019. His current research focuses on developing novel DNA-targeted alkylating agents for the treatment of glioblastoma and triple negative breast cancer, particularly addressing the challenges presented by the blood-brain barrier and the unique characteristics of these tumors. He is involved in various collaborative efforts, including work at the Auckland Cancer Society Research Centre and University College London, and he has a significant track record in securing research funding from various prestigious organizations.
University of New South Wales • Sydney, Australia
Honorary appointment as an Associate Professor in the School of Chemistry.
University of New South Wales • Sydney, Australia
Taught and conducted research in the School of Medical Sciences.
University College Dublin • Dublin, Ireland
Led cancer research initiatives and supervised graduate students.
Peter MacCallum Cancer Institute • Melbourne, Australia
Conducted research on cancer treatments.
Includes Business Intelligence, Enterprise Systems, and Cybersecurity Management streams.